Published in Calcif Tissue Int on July 11, 2013
Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia. Aging Clin Exp Res (2015) 1.49
Grip strength across the life course: normative data from twelve British studies. PLoS One (2014) 1.24
Sarcopenia: burden and challenges for public health. Arch Public Health (2014) 1.09
Osteoporosis and sarcopenia in older age. Bone (2015) 1.05
Maternal antenatal vitamin D status and offspring muscle development: findings from the Southampton Women's Survey. J Clin Endocrinol Metab (2013) 0.94
Determinants of Muscle and Bone Aging. J Cell Physiol (2015) 0.92
Osteoporosis and sarcopenia: two diseases or one? Curr Opin Clin Nutr Metab Care (2016) 0.87
Aging and the muscle-bone relationship. Physiology (Bethesda) (2015) 0.82
Diagnostic ultrasound estimates of muscle mass and muscle quality discriminate between women with and without sarcopenia. Front Physiol (2015) 0.82
Sarcopenia in daily practice: assessment and management. BMC Geriatr (2016) 0.81
Epidemiology of sarcopenia and insight into possible therapeutic targets. Nat Rev Rheumatol (2017) 0.79
The Future Prevalence of Sarcopenia in Europe: A Claim for Public Health Action. Calcif Tissue Int (2016) 0.78
Mortality in the Hertfordshire Ageing Study: association with level and loss of hand grip strength in later life. Age Ageing (2016) 0.76
The evaluation in terms of sarcopenia of patients with fibromyalgia syndrome. Wien Klin Wochenschr (2015) 0.75
The Prevalence and Prognostic Value of Low Muscle Mass in Cancer Patients: A Review of the Literature. Oncologist (2016) 0.75
Effects of bed-rest on urea and creatinine: correlation with changes in fat-free mass. PLoS One (2014) 0.75
Newly Developed Sarcopenia as a Prognostic Factor for Survival in Patients who Underwent Liver Transplantation. PLoS One (2015) 0.75
English translation and validation of the SarQoL®, a quality of life questionnaire specific for sarcopenia. Age Ageing (2016) 0.75
Epidemiology of Sarcopenia: Determinants Throughout the Lifecourse. Calcif Tissue Int (2017) 0.75
Nutrition and physical activity in the prevention and treatment of sarcopenia: systematic review. Osteoporos Int (2017) 0.75
Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci (2001) 42.21
A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol (1994) 30.72
Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med (1995) 20.53
Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing (2010) 17.45
Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci (2000) 15.54
Gait speed and survival in older adults. JAMA (2011) 15.01
Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol (1998) 10.23
A global clinical measure of fitness and frailty in elderly people. CMAJ (2005) 8.99
The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci (2006) 7.38
Bioelectrical impedance analysis--part I: review of principles and methods. Clin Nutr (2004) 7.24
Effects of a physical activity intervention on measures of physical performance: Results of the lifestyle interventions and independence for Elders Pilot (LIFE-P) study. J Gerontol A Biol Sci Med Sci (2006) 6.61
Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A Biol Sci Med Sci (2006) 6.08
Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med (1993) 6.08
Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc (2011) 5.96
What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15- to 83-year-old men. J Neurol Sci (1988) 5.07
Invited review: Aging and sarcopenia. J Appl Physiol (1985) (2003) 5.01
Frailty: an emerging research and clinical paradigm--issues and controversies. J Gerontol A Biol Sci Med Sci (2007) 4.98
Objectively measured physical capability levels and mortality: systematic review and meta-analysis. BMJ (2010) 4.64
Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc (2003) 4.02
Aging of skeletal muscle: a 12-yr longitudinal study. J Appl Physiol (1985) (2000) 3.47
Body-composition assessment via air-displacement plethysmography in adults and children: a review. Am J Clin Nutr (2002) 3.33
Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol (1985) (2000) 3.31
A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing (2011) 3.27
Hand-grip dynamometry predicts future outcomes in aging adults. J Geriatr Phys Ther (2008) 2.73
The relationship between leg power and physical performance in mobility-limited older people. J Am Geriatr Soc (2002) 2.65
Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc (2011) 2.34
Association of muscle power with functional status in community-dwelling elderly women. J Gerontol A Biol Sci Med Sci (2000) 2.20
Dynapenia and aging: an update. J Gerontol A Biol Sci Med Sci (2011) 2.19
Muscle strength, disability and mortality. Scand J Med Sci Sports (2003) 2.09
Metabolic benefits of resistance training and fast glycolytic skeletal muscle. Am J Physiol Endocrinol Metab (2010) 2.06
Use of the Short Physical Performance Battery Score to predict loss of ability to walk 400 meters: analysis from the InCHIANTI study. J Gerontol A Biol Sci Med Sci (2009) 1.83
Skeletal muscle power: a critical determinant of physical functioning in older adults. Exerc Sport Sci Rev (2012) 1.83
Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status. J Gerontol A Biol Sci Med Sci (2003) 1.48
Lower extremity power training in elderly subjects with mobility limitations: a randomized controlled trial. Aging Clin Exp Res (2008) 1.43
Quadriceps muscle strength, contractile properties, and motor unit firing rates in young and old men. Muscle Nerve (1999) 1.43
Measurement of human muscle fatigue. J Neurosci Methods (1997) 1.42
Dual-energy X-ray absorptiometry is a valid tool for assessing skeletal muscle mass in older women. J Nutr (2007) 1.38
Dual-energy X-ray absorptiometry and body composition. Curr Opin Clin Nutr Metab Care (2005) 1.21
Validation of a bioelectrical impedance analysis equation to predict appendicular skeletal muscle mass (ASMM). Clin Nutr (2003) 1.18
Muscle performance and physical function are associated with voluntary rate of neuromuscular activation in older adults. J Gerontol A Biol Sci Med Sci (2010) 1.15
Muscular endurance repetitions to predict bench press strength in men of different training levels. J Sports Med Phys Fitness (1995) 1.09
Myotendinous plasticity to ageing and resistance exercise in humans. Exp Physiol (2006) 1.09
Simple equations to predict concentric lower-body muscle power in older adults using the 30-second chair-rise test: a pilot study. Clin Interv Aging (2010) 1.04
Fluoride for treating postmenopausal osteoporosis. Cochrane Database Syst Rev (2000) 1.04
Estimation of thigh muscle cross-sectional area by dual-energy X-ray absorptiometry in frail elderly patients. Am J Clin Nutr (2007) 1.04
Body composition analysis techniques in the aged adult: indications and limitations. Curr Opin Clin Nutr Metab Care (2009) 1.03
One-repetition maximum strength test represents a valid means to assess leg strength in vivo in humans. J Sports Sci (2009) 1.00
Grip strength and lower limb extension power in 19-72-year-old Danish men and women: the Health2006 study. BMJ Open (2011) 0.99
Body CT: technical advances for improving safety. AJR Am J Roentgenol (2011) 0.98
Loss of appendicular muscle mass and loss of muscle strength in young postmenopausal women. J Gerontol A Biol Sci Med Sci (2007) 0.97
Comparison of the Jamar dynamometer and the Martin vigorimeter for grip strength measurements in a healthy elderly population. Scand J Rehabil Med (1995) 0.96
Characteristics of muscle fiber type are predictive of skeletal muscle mass and strength in elderly men. J Am Geriatr Soc (2010) 0.91
Can dual energy X-ray absorptiometry provide a valid assessment of changes in thigh muscle mass with strength training in older adults? Eur J Clin Nutr (2007) 0.89
Methods for the assessment of peripheral muscle fatigue and its energy and metabolic determinants in COPD. J Bras Pneumol (2009) 0.88
Assessment of analytical methods used to measure changes in body composition in the elderly and recommendations for their use in phase II clinical trials. J Nutr Health Aging (2011) 0.87
Evidence-based criteria for sarcopenia with clinically important weakness. Semin Arthritis Rheum (2012) 0.82
Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res (1987) 24.27
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med (2001) 16.81
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int (2006) 11.05
Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med (2001) 9.57
Two categories of c/c ratios for higher plants. Plant Physiol (1971) 7.48
How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups? Am J Epidemiol (1996) 7.12
World-wide projections for hip fracture. Osteoporos Int (1997) 6.83
Impure science: AIDS, activism, and the politics of knowledge. Med Soc (Berkeley) (1996) 6.02
Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging (2009) 5.98
Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int (2005) 5.54
Attenuation of skeletal muscle and strength in the elderly: The Health ABC Study. J Appl Physiol (1985) (2001) 5.35
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2008) 5.27
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2012) 4.88
Metabolic fractionation of C & C in plants. Plant Physiol (1961) 4.38
Fatigue, alcohol and performance impairment. Nature (1997) 4.31
Diminishing returns from mutation supply rate in asexual populations. Science (1999) 4.25
An estimate of the worldwide prevalence, mortality and disability associated with hip fracture. Osteoporos Int (2004) 4.24
Effects of beta-adrenergic blockade on the cardiac response to maximal and submaximal exercise in man. J Clin Invest (1965) 4.23
Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science (1999) 4.10
Vitamin-D-receptor-gene polymorphisms and change in lumbar-spine bone mineral density. Lancet (1995) 3.82
Mortality after osteoporotic fractures. Osteoporos Int (2003) 3.68
Appendicular skeletal muscle mass: effects of age, gender, and ethnicity. J Appl Physiol (1985) (1997) 3.63
Mechanism of carbon isotope fractionation associated with lipid synthesis. Science (1977) 3.62
Tamoxifen: disease prevention or disease substitution? Lancet (1992) 3.57
Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med (1992) 3.54
Bone densitometry in clinical practice. BMJ (1995) 3.48
Description of 1,108 older patients referred by their physician to the "Geriatric Frailty Clinic (G.F.C) for Assessment of Frailty and Prevention of Disability" at the gerontopole. J Nutr Health Aging (2014) 3.37
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int (2010) 3.36
What aspects of body fat are particularly hazardous and how do we measure them? Int J Epidemiol (2005) 3.34
The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res (1996) 3.25
Muscle strength and body mass index as long-term predictors of mortality in initially healthy men. J Gerontol A Biol Sci Med Sci (2000) 3.20
Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study. Diabetologia (2005) 3.20
Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res (2002) 3.16
Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int (2011) 3.04
Conservation. Challenges to the future conservation of the Antarctic. Science (2012) 3.01
Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1998) 2.81
Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J Exp Med (1998) 2.80
IOF position statement: vitamin D recommendations for older adults. Osteoporos Int (2010) 2.79
Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women. J Clin Oncol (1996) 2.76
Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study. Endoscopy (2013) 2.76
Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas (2009) 2.74
Current use of bisphosphonates in oncology. International Bone and Cancer Study Group. J Clin Oncol (1998) 2.73
Evidence for alteration of the vitamin D-endocrine system in blacks. J Clin Invest (1985) 2.72
A global representation of vitamin D status in healthy populations. Arch Osteoporos (2012) 2.69
The assessment of vertebral deformity: a method for use in population studies and clinical trials. Osteoporos Int (1993) 2.66
Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest (1985) 2.61
The I.A.N.A Task Force on frailty assessment of older people in clinical practice. J Nutr Health Aging (2008) 2.53
Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer. J Clin Oncol (1993) 2.50
Impact of nutrition on muscle mass, strength, and performance in older adults. Osteoporos Int (2012) 2.48
Cognitive frailty: rational and definition from an (I.A.N.A./I.A.G.G.) international consensus group. J Nutr Health Aging (2013) 2.44
Interpretation and use of FRAX in clinical practice. Osteoporos Int (2011) 2.43
Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. J Clin Endocrinol Metab (1992) 2.42
Bone-density measurement. Lancet (1992) 2.38
The prevalence of carbon-13 in respiratory carbon dioxide as an indicator of the types of endogenous substrate. The change from lipid to carbohydrate during the respiratory rise in potato slices. J Gen Physiol (1970) 2.38
Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J Clin Endocrinol Metab (1991) 2.27
Bone strength and its determinants. Osteoporos Int (2003) 2.25
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel. Ann Oncol (2007) 2.24
Interspecies differences in bone composition, density, and quality: potential implications for in vivo bone research. Endocrinology (1998) 2.24
Fracture risk following an osteoporotic fracture. Osteoporos Int (2003) 2.21
Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis. Osteoporos Int (1999) 2.20
Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study. J Clin Endocrinol Metab (1998) 2.14
Oxygen and hydrogen isotopic ratios in plant cellulose. Science (1977) 2.10
Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure. BMJ (1995) 2.10
The prediction of visceral fat by dual-energy X-ray absorptiometry in the elderly: a comparison with computed tomography and anthropometry. Int J Obes Relat Metab Disord (2002) 2.08
A simple tool to identify asian women at increased risk of osteoporosis. Osteoporos Int (2001) 2.06
Weight stability masks sarcopenia in elderly men and women. Am J Physiol Endocrinol Metab (2000) 2.05
Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience. J Clin Oncol (1997) 2.02
Adrenocortical function in acquired immunodeficiency syndrome. J Clin Endocrinol Metab (1987) 1.99
Spatial and temporal operation of the Scotia Sea ecosystem: a review of large-scale links in a krill centred food web. Philos Trans R Soc Lond B Biol Sci (2007) 1.95
The relation of rational and experiential information processing styles to personality, basic beliefs, and the ratio-bias phenomenon. J Pers Soc Psychol (1999) 1.94
Patient-reported autonomic symptoms in Parkinson disease. Neurology (2007) 1.93
Incidence of hip fracture over a 10-year period (1991-2000): reversal of a secular trend. Bone (2007) 1.88
Risk of vertebral fracture in women with rheumatoid arthritis. BMJ (1993) 1.87
The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design. Osteoporos Int (2009) 1.85
Waist circumference and sagittal diameter reflect total body fat better than visceral fat in older men and women. The Health, Aging and Body Composition Study. Ann N Y Acad Sci (2000) 1.84
Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report. Osteoporos Int (2010) 1.83
Gain in bone mineral mass in prepubertal girls 3.5 years after discontinuation of calcium supplementation: a follow-up study. Lancet (2001) 1.82
Treatment failure in osteoporosis. Osteoporos Int (2012) 1.82
Learning to perform endoscopic resection of esophageal neoplasia is associated with significant complications even within a structured training program. Endoscopy (2011) 1.82
Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins. Am J Physiol (1997) 1.81
The apparent incidence of hip fracture in Europe: a study of national register sources. Osteoporos Int (1992) 1.81
Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency. J Clin Invest (1997) 1.81
Measurement of fat mass using DEXA: a validation study in elderly adults. J Appl Physiol (1985) (2000) 1.81
Endoscopic ultrasound-guided fine-needle aspiration of pancreatic cystic lesions provides inadequate material for cytology and laboratory analysis: initial results from a prospective study. Endoscopy (2011) 1.81
Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis Study. J Bone Miner Res (1995) 1.79
Independent and opposite associations of waist and hip circumferences with diabetes, hypertension and dyslipidemia: the AusDiab Study. Int J Obes Relat Metab Disord (2004) 1.78
Coordinator-based systems for secondary prevention in fragility fracture patients. Osteoporos Int (2011) 1.77
Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men. J Clin Endocrinol Metab (2013) 1.77
Late-onset hypogonadism and mortality in aging men. J Clin Endocrinol Metab (2013) 1.77
Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX). Osteoporos Int (2008) 1.77
Enhanced services and stipends for foster parents: effects on retention rates and outcomes for children. Child Welfare (1992) 1.76
The multitude and diversity of environmental carcinogens. Environ Res (2007) 1.73
Osteoporosis in the European Union: a compendium of country-specific reports. Arch Osteoporos (2013) 1.72